Kupffer cell-mediated IL-2 suppression of CYP3A activity in human hepatocytes

Drug Metabolism and Disposition

Volumn 32, Issue 3, 2004, Pages 359-363

  Sunman, Jeffrey A ^a   Hawke, Roy L ^a   LeCluyse, Edward L ^a   Kashuba, Angela D M ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University of North Carolina   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6;

ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL TYPE; CHRONIC LIVER DISEASE; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; KUPFFER CELL; LIVER CELL CULTURE; LIVER DISEASE; MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ARYL HYDROCARBON HYDROXYLASES; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; HEPATOCYTES; HUMANS; INDICATORS AND REAGENTS; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-6; KUPFFER CELLS; LIVER; OXIDOREDUCTASES, N-DEMETHYLATING;

STAPHYLOCOCCUS PHAGE 3A;

EID: 1342344700     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.32.3.359     Document Type: Article

References (16)

1. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P, and Guillouzo A (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44:707-715.
2. de Boer AW, Markowitz N, Lane HC, Saravolatz LD, Koletar SL, Donabedian H, Yoshizawa C, Duliege AM, Fyfe G, and Mitsuyasu RT (2003) A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4- and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4+ T cells. Clin Immunol 106:188-196.
3. Elias D, Farace F, Triebel F, Hattchouel JM, Pignon JP, Lecesne A, Rougier P, Lasser P, Duvillard P, and Escudier B (1995) Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectum. J Am Coll Surg 181:303-310.
4. Elkahwaji J, Robin MA, Berson A, Tinel M, Letteron P, Labbe G, Beaune P, Elias D, Rougier P, Escudier B, et al. (1999) Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy. Biochem Pharmacol 57:951-954.
5. Faucette SR, Hawke RL, Shord SS, LeCluyse EL, and Lindley CM (2001) Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation. Drug Metab Dispos 29:123-129.
6. Kashuba ADM, Hawke RL, Tonkin J, and LeCluyse EL (2000) Direct exposure to interleukins (IL)-2, -10 and -12 does not significantly suppress CYP3A activity in human hepatocytes. Clin Pharmacol Ther 67:100.
7. Muntane-Relat J, Ourlin JC, Domergue J, and Maurel P (1995) Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 22:1143-1153.
8. Piscitelli SC, Forrest A, Vogel S, Chaitt D, Metcalf J, Stevens R, Baseler M, Davey RT, and Kovacs JA (1998a) Pharmacokinetic modeling of recombinant interleukin-2 in patients with human immunodeficiency virus infection. Clin Pharmacol Ther 64:492-498.
9. Piscitelli SC, Vogel S, Figg WD, Raje S, Forrest A, Metcalf JA, Baseler M, and Falloon J (1998b) Alteration in indinavir clearance during interleukin-2 infusions in patients infected with the human immunodeficiency virus. Pharmacotherapy 18:1212-1216.
10. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, and McCaughan GW (2002) Insights into the pathobiology of hepatitis C virus-associated cirrhosis. Am J Pathol 160:641-654.
11. Smedsrod B and Pertoft H (1985) Preparation of pure hepatocytes and reticuloendothelial cells in high yield from a single rat liver by means of Percoll centrifugation and selective adherence. J Leukoc Biol 38:213-230.
12. Sun WB, Han BL, Peng ZM, Li K, Ji Q, Chen J, Wang HZ, and Ma RL (1998) Effect of aging on cytoskeleton system of Kupffer cell and its phagocytic capacity, World J Gastroenterol 4:77-79.
13. Tinel M, Elkahwaji J, Robin MA, Fardel N, Descatoire V, Haouzi D, Berson A, and Pessayre D (1999) Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes. J Pharmacol Exp Ther 289:649-655.
14. Tinel M, Robin MA, Doostzadeh J, Maratrat M, Ballet F, Fardel N, el Kahwaji J, Beaune P, Daujat M, Labbe G, and Pessayre D (1995) The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes. Gastroenterology 109:1589-1599.
15. Tippin TK, Hamilton G, Moore L, Beaudet EJ, Jolley S, Brodie TA, Andrews RC, Becherer JD, McDougald DL, Gaul MD, et al. (2003) CYP3A induction by N-hydroxyformamide tumor necrosis factor-alpha converting enzyme/matrix metalloproteinase inhibitors use of a pregnane X receptor activation assay and primary hepatocyte culture for assessing induction potential in humans. Drug Metab Dispos 31:870-877.
16. Valatas V, Xidakis C, Roumpaki H, Kolios G, and Kouroumalis EA (2003) Isolation of rat Kupffer cells: a combined methodology for highly purified primary cultures. Cell Biol Int 27:67-73.